Pharmacoeconomic Analysis of Cost Comparison Between Calcium Channel Blocker (CCB) and Angiotensin II Receptor Blocker (ARB) Antihypertensive Drugs in Hospitalized Hypertensive Patients at RSU Royal Prima. JFM [Internet]. 2026 Apr. 30 [cited 2026 May 6];8(2):1146-55. Available from: https://ejournal.medistra.ac.id/index.php/JFM/article/view/3371